Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Lakefront Biotherapeutics NV (GXE) vs. Competitors

6 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:GXELakefront Biotherapeutics NVEUR 30.14EUR 2.05B4.0811.30%Moderate SellUnlock the DE:GXE analyst price target with TipRanks PremiumDE:GXEUnlock the DE:GXE top-analyst price target with TipRanks Premium
NL:PHARMPharming GroupEUR 1.14EUR 822.09M35.75-23.37%―Unlock the NL:PHARM analyst price target with TipRanks PremiumDE:GXE vs NL:PHARMUnlock the NL:PHARM top-analyst price target with TipRanks Premium
NL:VVYVivoryon Therapeutics AGEUR 0.77EUR 22.45M-3.34-53.17%―Unlock the NL:VVY analyst price target with TipRanks PremiumDE:GXE vs NL:VVYUnlock the NL:VVY top-analyst price target with TipRanks Premium

Performance Comparison

-75%-50%-25%0%25%50%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:GXELakefront Biotherapeutics NV30.143.5213.22%
NL:PHARMPharming Group1.14-0.25-18.03%
NL:VVYVivoryon Therapeutics AG0.77-0.87-53.11%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts